Loading clinical trials...
Loading clinical trials...
ADVICE: A Dose Range Finding Study of Formoterol Administered Once Daily in the Evening in Combination With Ciclesonide Using the Ultrahaler™ Versus Monotherapy of Each Drug in Asthmatic Patients
Conditions
Interventions
Ciclesonide/Formoterol Combination
Locations
26
France
Altana Pharma/Nycomed
Grenoble, France
Altana Pharma/Nycomed
Montpellier, France
Altana Pharma/Nycomed
Berlin, Germany
Altana Pharma/Nycomed
Großhansdorf, Germany
Altana Pharma/Nycomed
Mainz, Germany
Altana Pharma/Nycomed
Rüdersdorf, Germany
Start Date
July 1, 2005
Primary Completion Date
January 1, 2006
Completion Date
January 1, 2006
Last Updated
December 5, 2016
NCT02327897
NCT07219173
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions